Genomic tests are revolutionizing prostate cancer care, enabling precise, personalized treatment tailored to each patient.

A new review led by researchers at Moffitt Cancer Center assessed how three genomic tests — Decipher, Oncotype DX Genomic Prostate Score (GPS) and Prolaris — can help doctors make better decisions ...

A new review led by researchers at Moffitt Cancer Center assessed how three genomic tests - Decipher, Oncotype DX Genomic Prostate Score (GPS) and Prolaris - can help doctors make better decisions ...

A new review led by researchers at Moffitt Cancer Center assessed how three genomic tests — Decipher, Oncotype DX Genomic ...

Tissue-based genomic classifier tests, developed to improve prostate cancer risk assessment and treatment recommendations, ...

In this systematic review, ten studies reported risk reclassification of prostate cancer with genome classifier testing, with ...

We've seen Bruce and Damian Wayne go through this dance time and time again, and it's just a tired and worn out Batman and ...

SO THE WDSU NEWS VEHICLE, THIS IS MICHEL VARISCO GLEASON. THIS IS STEVE GLEASON’S WIFE, STEVE. THIS IS THIS IS THEIR DAUGHTER, GRAY. WHAT’S UP? YOU WARM NOW? THEY WANTED THE CAR TO GET WARM ...

A systematic review found that while genomic classifier (GC) tests may influence risk classifications or treatment decisions for patients with localized prostate cancer (PCa), there is a need for ...

The following is a summary of “Prognostic value of intraductal carcinoma subtypes and postoperative radiotherapy for ...

Henry Patten and Harri Heliovaara have rallied from losing a contentious first set to win the Australian Open men's doubles ...